PT90722A - Processo de preparacao de uma forma de dosagem de libertacao controlada a base de uma 3-alquilxantina - Google Patents

Processo de preparacao de uma forma de dosagem de libertacao controlada a base de uma 3-alquilxantina

Info

Publication number: PT90722A
Authority: PT; Portugal
Prior art keywords: alkylxxine; preparing; dosage based; dosage form; controlled liberation
Prior art date: 1988-06-02

Application number

PT90722A

Other languages

English (en)

Other versions

PT90722B (pt

Inventor

Joanne Heafield

Sandra Therese Antoi Malkowska

Original Assignee

Euro Celtique Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-06-02

Filing date

1989-06-01

Publication date

1989-12-29

1989-06-01 Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa

1989-12-29 Publication of PT90722A publication Critical patent/PT90722A/pt

1994-11-30 Publication of PT90722B publication Critical patent/PT90722B/pt

Links

XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
239000002552 dosage form Substances 0.000 abstract 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 2
238000013270 controlled release Methods 0.000 abstract 1
229920001477 hydrophilic polymer Polymers 0.000 abstract 1
229920001600 hydrophobic polymer Polymers 0.000 abstract 1
230000008018 melting Effects 0.000 abstract 1
238000002844 melting Methods 0.000 abstract 1
239000006186 oral dosage form Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
229960000278 theophylline Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PT90722A 1988-06-02 1989-06-01 Processo de preparacao de uma forma de dosagem de libertacao controlada a base de uma 3-alquilxantina PT90722B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB888813064A GB8813064D0 (en)	1988-06-02	1988-06-02	Controlled release dosage forms having defined water content

Publications (2)

Publication Number	Publication Date
PT90722A true PT90722A (pt)	1989-12-29
PT90722B PT90722B (pt)	1994-11-30

Family

ID=10637952

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT90722A PT90722B (pt)	1988-06-02	1989-06-01	Processo de preparacao de uma forma de dosagem de libertacao controlada a base de uma 3-alquilxantina

Country Status (19)

Country	Link
US (1)	US5091189A (pt)
EP (1)	EP0344960B1 (pt)
JP (1)	JPH0816060B2 (pt)
KR (1)	KR0136279B1 (pt)
AT (1)	ATE83925T1 (pt)
AU (1)	AU610401B2 (pt)
CA (1)	CA1323834C (pt)
DE (1)	DE68904119T2 (pt)
DK (1)	DK175130B1 (pt)
ES (1)	ES2053989T3 (pt)
FI (1)	FI93695C (pt)
GB (2)	GB8813064D0 (pt)
GR (1)	GR3007088T3 (pt)
IE (1)	IE61998B1 (pt)
IL (1)	IL90462A (pt)
NO (1)	NO176232C (pt)
NZ (1)	NZ229372A (pt)
PT (1)	PT90722B (pt)
ZA (1)	ZA894201B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6262115B1 (en) *	1995-05-22	2001-07-17	Alza Coporation	Method for the management of incontinence
US5912268A (en) *	1995-05-22	1999-06-15	Alza Corporation	Dosage form and method for treating incontinence
CA2314896C (en) *	1997-12-22	2005-09-13	Euro-Celtique, S.A.	A method of preventing abuse of opioid dosage forms
JP2001526228A (ja)	1997-12-22	2001-12-18	ユーロ−セルティーク，エス．エイ．	オピオイド作動薬／拮抗薬の併用
AU1738800A (en)	1998-11-23	2000-06-13	Bonnie Davis	Dosage formulations for acetylcholinesterase inhibitors
HU229705B1 (en)	2000-02-08	2014-05-28	Euro Celtique Sa	Tamper-resistant oral opioid agonist formulations
CN1525851A (zh)	2001-05-11	2004-09-01	��ҩ��޹�˾	抗滥用阿片样物质控释剂型
US7052706B2 (en) *	2001-06-08	2006-05-30	Nostrum Pharmaceuticals, Inc.	Control release formulation containing a hydrophobic material as the sustained release agent
SI1416842T1 (sl) *	2001-07-18	2009-06-30	Euro Celtique Sa	Farmacevtske kombinacije oksikodona in naloksona
ATE431738T1 (de)	2001-08-06	2009-06-15	Euro Celtique Sa	Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
AU2002324624A1 (en)	2001-08-06	2003-02-24	Euro-Celtique S.A.	Sequestered antagonist formulations
US20030044458A1 (en) *	2001-08-06	2003-03-06	Curtis Wright	Oral dosage form comprising a therapeutic agent and an adverse-effect agent
IN192180B (pt) *	2001-09-28	2004-03-06	Ranbaxy Lab
CA2479350A1 (en) *	2002-03-15	2003-09-25	Cypress Bioscience, Inc.	Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
EP1492505B1 (en)	2002-04-05	2015-06-03	Euro-Celtique S.A.	Pharmaceutical preparation containing oxycodone and naloxone
US7815934B2 (en)	2002-09-20	2010-10-19	Alpharma Pharmaceuticals, Llc	Sequestering subunit and related compositions and methods
US20060003004A1 (en) *	2002-10-25	2006-01-05	Collegium Pharmaceutical, Inc.	Pulsatile release compositions of milnacipran
US20040121010A1 (en) *	2002-10-25	2004-06-24	Collegium Pharmaceutical, Inc.	Pulsatile release compositions of milnacipran
WO2004067039A1 (en) *	2003-01-28	2004-08-12	Collegium Pharmaceutical, Inc.	Multiparticulate compositions of milnacipran for oral administration
US20040202717A1 (en) *	2003-04-08	2004-10-14	Mehta Atul M.	Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) *	2003-04-21	2008-07-31	Euro Celtique Sa	Pharmaceutical products
EP1604666A1 (en) *	2004-06-08	2005-12-14	Euro-Celtique S.A.	Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
ES2317313T3 (es) *	2004-10-19	2009-04-16	Krka, Tovarna Zdravil, D.D., Novo Mesto	Composicion farmaceutica solida que comprende clorhidrato de donepezilo.
EP1702558A1 (en) *	2005-02-28	2006-09-20	Euro-Celtique S.A.	Method and device for the assessment of bowel function
EP1942875B1 (en) *	2005-08-24	2015-08-12	Rubicon Research Private Limited	Controlled release formulation
SI2719378T1 (sl)	2006-06-19	2016-11-30	Alpharma Pharmaceuticals Llc	Farmacevtski sestavki
PL2068816T3 (pl) *	2006-09-29	2018-03-30	The Procter And Gamble Company	Kompozycje do higieny jamy ustnej zawierające sieci żelowe
EP2224808A4 (en) *	2007-12-17	2013-11-27	Alpharma Pharmaceuticals Llc	PHARMACEUTICAL COMPOSITION
US20100151014A1 (en) *	2008-12-16	2010-06-17	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition
US8623418B2 (en) *	2007-12-17	2014-01-07	Alpharma Pharmaceuticals Llc	Pharmaceutical composition
RU2478388C2 (ru) *	2008-07-07	2013-04-10	Еуро-Селтик С.А.	Фармацевтическая композиция, содержащая опиоидный антагонист, для лечения задержки мочи
MY152279A (en)	2009-03-10	2014-09-15	Euro Celtique Sa	Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10071089B2 (en)	2013-07-23	2018-09-11	Euro-Celtique S.A.	Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
CN114053235B (zh) *	2020-08-07	2023-07-18	广州白云山光华制药股份有限公司	茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3965256A (en) *	1972-05-16	1976-06-22	Synergistics	Slow release pharmaceutical compositions
US4443428A (en) *	1982-06-21	1984-04-17	Euroceltique, S.A.	Extended action controlled release compositions
FR2535202B1 (fr) *	1982-11-03	1985-08-09	Fabre Sa Pierre	Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) *	1984-08-13	1988-05-10	Alza Corporation	Process for manufacturing dosage form
US4753800A (en) *	1985-10-04	1988-06-28	Warner-Lambert Company	Medicament adsorbates and their preparation
US4892742A (en) *	1985-11-18	1990-01-09	Hoffmann-La Roche Inc.	Controlled release compositions with zero order release
GB8613688D0 (en) *	1986-06-05	1986-07-09	Euro Celtique Sa	Pharmaceutical composition
DE3750145T2 (de) *	1986-06-10	1994-11-03	Euro Celtique Sa	Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein.
GB8626098D0 (en) *	1986-10-31	1986-12-03	Euro Celtique Sa	Controlled release hydromorphone composition
GB8628728D0 (en) *	1986-12-02	1987-01-07	Euro Celtique Sa	Spheroids

1988
- 1988-06-02 GB GB888813064A patent/GB8813064D0/en active Pending
1989
- 1989-05-19 GB GB8911629A patent/GB2219207B/en not_active Expired - Fee Related
- 1989-05-23 AT AT89305209T patent/ATE83925T1/de not_active IP Right Cessation
- 1989-05-23 DE DE8989305209T patent/DE68904119T2/de not_active Expired - Lifetime
- 1989-05-23 ES ES89305209T patent/ES2053989T3/es not_active Expired - Lifetime
- 1989-05-23 EP EP89305209A patent/EP0344960B1/en not_active Expired - Lifetime
- 1989-05-24 AU AU35127/89A patent/AU610401B2/en not_active Expired
- 1989-05-29 CA CA000600949A patent/CA1323834C/en not_active Expired - Lifetime
- 1989-05-30 IL IL90462A patent/IL90462A/xx unknown
- 1989-05-31 NZ NZ229372A patent/NZ229372A/en unknown
- 1989-06-01 JP JP1140229A patent/JPH0816060B2/ja not_active Expired - Lifetime
- 1989-06-01 NO NO892229A patent/NO176232C/no not_active IP Right Cessation
- 1989-06-01 KR KR1019890007506A patent/KR0136279B1/ko not_active Expired - Lifetime
- 1989-06-01 DK DK198902668A patent/DK175130B1/da not_active IP Right Cessation
- 1989-06-01 FI FI892664A patent/FI93695C/fi active IP Right Grant
- 1989-06-01 PT PT90722A patent/PT90722B/pt not_active IP Right Cessation
- 1989-06-02 ZA ZA894201A patent/ZA894201B/xx unknown
- 1989-06-12 IE IE174489A patent/IE61998B1/en not_active IP Right Cessation
1991
- 1991-05-17 US US07/704,714 patent/US5091189A/en not_active Expired - Lifetime
1993
- 1993-02-17 GR GR930400321T patent/GR3007088T3/el unknown

Also Published As

Publication number	Publication date
IE891744L (en)	1989-12-02
ZA894201B (en)	1990-03-28
GR3007088T3 (pt)	1993-07-30
DE68904119T2 (de)	1993-06-09
IL90462A0 (en)	1990-01-18
FI93695C (fi)	1995-05-26
KR900000077A (ko)	1990-01-30
DE68904119D1 (de)	1993-02-11
DK175130B1 (da)	2004-06-14
GB8813064D0 (en)	1988-07-06
JPH0225420A (ja)	1990-01-26
JPH0816060B2 (ja)	1996-02-21
AU610401B2 (en)	1991-05-16
NO176232B (no)	1994-11-21
NO176232C (no)	1995-03-01
ES2053989T3 (es)	1994-08-01
EP0344960A2 (en)	1989-12-06
DK266889D0 (da)	1989-06-01
IE61998B1 (en)	1994-12-14
FI93695B (fi)	1995-02-15
FI892664L (fi)	1989-12-03
GB2219207B (en)	1992-01-02
ATE83925T1 (de)	1993-01-15
GB8911629D0 (en)	1989-07-05
EP0344960B1 (en)	1992-12-30
NO892229D0 (no)	1989-06-01
IL90462A (en)	1993-01-31
PT90722B (pt)	1994-11-30
US5091189A (en)	1992-02-25
FI892664A0 (fi)	1989-06-01
NZ229372A (en)	1991-07-26
KR0136279B1 (ko)	1998-04-25
AU3512789A (en)	1989-12-07
NO892229L (no)	1989-12-04
EP0344960A3 (en)	1990-03-07
DK266889A (da)	1989-12-03
CA1323834C (en)	1993-11-02
GB2219207A (en)	1989-12-06

Legal Events

Date

Code

Title

Description

1994-11-30

FG3A

Patent granted, date of granting

Effective date: 19940516

2009-06-09

MM4A

Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20090601

Publication	Publication Date	Title
PT90722A (pt)	1989-12-29	Processo de preparacao de uma forma de dosagem de libertacao controlada a base de uma 3-alquilxantina
GB8825024D0 (en)	1988-11-30	Drug carrier
IT8941653A0 (it)	1989-07-07	Dispositivo per la correzione delle anomalie di rifrazione dell'occhio.
FI891338L (fi)	1989-09-25	Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi
HUT61196A (en)	1992-12-28	Process for producing pharmaceutical composition which may be dropped in the eye
DE69001573D1 (de)	1993-06-17	Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
ATE33553T1 (de)	1988-05-15	Inerte pharmazeutische matrize aus polykaprolakton und verfahren zur herstellung einer oral galenischen form.
IT1215332B (it)	1990-02-08	Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
FI860602A0 (fi)	1986-02-10	Anordning foer foersaettande i vertikal roerelse av en sits, isynnerhet en patientstol.
FR2592588B1 (fr)	1988-05-06	Mur d'escalade artificiel et procede de realisation de ce mur.
GB2196973B (en)	1991-01-02	Hydrophilic copolymer and the method for producing thereof
IT8921229A0 (it)	1989-07-19	Metodo per determinare la velocita' dei fili.
FR2518881B1 (fr)	1986-02-21	Medicaments a base de 26,23-lactones de la 25-hydroxyvitamine d3, utiles notamment pour agir sur la concentration en calcium du serum
DE3862788D1 (de)	1991-06-20	Fluessige oxydationsmodifizierte ethylenische statistische copolymere, verfahren zur herstellung und deren verwendung.
EP0292806A3 (en)	1990-10-17	Substituted vinyl cephalosporins, process for their preparation and their use as medicines
DE3776507D1 (de)	1992-03-12	Amphipathische polymerisierbare vinylmonomere, davon abgeleitete vinylharzteilchen und deren herstellung.
IT1220809B (it)	1990-06-21	Metodo per l'avanzamento del piede particolarmente nei pedali per velocipedi
PT87804A (pt)	1989-05-31	Nacelle inclinable ou reversible notamment pour voiture d'enfant
IT1244562B (it)	1994-07-28	Agente per la prevenzione ed il trattamento dell'opacita' del cristallino.
ES2052701T3 (es)	1994-07-16	Agente hipouricemico que contiene ponalrestat.
Jack	1986	Aspects of physisorption kinetics
Kuczmann	1988	Behaviour of PVC Powder Grains Produced Using Suspension Technology, in Processing
IT8720014A0 (it)	1987-04-07	Cristallino artificiale dell'occhio.
LV5266A3 (lv)	1993-10-10	Panemiens 1,3-aizvietoto tetrahidro-1h-tieno-(3,4-d)-imidazol-2-(3h)-on-4-4-iliden-pentanskabju esteru iegusanai
IT8620470A0 (it)	1986-05-16	Procedimento per la polimerizzazione in sospensione acquosa di monomeri vinilici contenenti alogeno.